| Pharmaceutical active ingredients: |
| Terbinafine Hydrochloride |
| Available forms, composition and doses of PHL-Terbinafine: |
| Tablets; Oral; Terbinafine Hydrochloride 250 mg |
| PHL-Terbinafine medical category: |
| Human:AllylaminesAntifungalsTopical antifungals and antiparasites |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D01AE15 - TerbinafineD01BA02 - Terbinafine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pharmel |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nu-Terbinafine | Terbinafine Hydrochloride | Nu-Pharm |
| Octosan | Terbinafine Hydrochloride | Sanofi-Aventis |
| Onychon | Terbinafine Hydrochloride | Zentiva |
| Orlasil | Terbinafine Hydrochloride | Bright Future Pharmaceutical Laboratories; Zuellig Pharma |
| Patir | Terbinafine Hydrochloride | Rafa Laboratories |
| PMS-Terbinafine | Terbinafine Hydrochloride | Pharmascience |
| Riva-Terbinafine | Terbinafine Hydrochloride | Riva Laboratoire |
| Tamsil | Terbinafine Hydrochloride | Arrow Pharmaceuticals |
| Tebif | Terbinafine Hydrochloride | Unichem |
| Tebinisil | Terbinafine Hydrochloride | Medreich; DKSH |